Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer

Brain metastases (BM) have been closely associated with increased morbidity and poor survival outcomes in patients with non-small cell lung cancer (NSCLC). Excluding risk factors in histological subtypes, genomic alterations, including epidermal growth factor receptor mutations and anaplastic lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Nian, Rui, Jiang, Huihui, Zhao, Jiangman, Hou, Wanle, Zhang, Hua, Ma, Jiangtao, Lv, Pengbiao, Jiang, Lisha, Wang, Yongpan, Xu, Yue, Wu, Shouxin, Lou, Jingwei, Li, Wanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291252/
https://www.ncbi.nlm.nih.gov/pubmed/35796015
http://dx.doi.org/10.3892/ijo.2022.5390

Ejemplares similares

Ejemplares similares